Artemis Therapeutics, Inc. – ‘8-K’ for 4/4/08

On:  Friday, 4/4/08, at 3:10pm ET   ·   For:  4/4/08   ·   Accession #:  1178913-8-866   ·   File #:  0-24431

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         4     11K 
 2: EX-3.2      Articles of Incorporation/Organization or By-Laws      1      5K 

8-K   —   Current Report
Document Table of Contents

8-K
1st Page of 4
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

 CURRENT REPORT PURSUANT
 TO SECTION 13 OR 15(D) OF THE
 SECURITIES EXCHANGE ACT OF 1934

 Date of report (Date of earliest event reported) MARCH 31, 2008

INKSURE TECHNOLOGIES, INC.
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)

Delaware
--------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)

0-24431                                        84-1417774 
--------------------------------------------------------------------------------
   (Commission File Number)                    (IRS Employer Identification No.)

1770 N.W. 64th Street, Suite 350, Fort Lauderdale, FL                 33309     
--------------------------------------------------------------------------------
    (Address of Principal Executive Offices)                      (Zip Code)

(954) 772-8507
--------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)

--------------------------------------------------------------------------------
 (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to 
simultaneously satisfy the filing obligation of the registrant under any of the 
following provisions (SEE General Instruction A.2. below):                      

   [_]  Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)                                            

     [_]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)                                             

  [_]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))                          

  [_]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))                          

8-K
2nd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 2nd
ITEM 5.03. AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL  
YEAR.                                                                           

We amended the time period and manner of notice for any special meeting as      
described in Section 5 of the company's Bylaws. Formerly, notice of any special 
meeting must have been given at least five (5) days prior to a meeting by       
written notice delivered personally, mailed or delivered by fax to each director
at his business address. As amended, Section 5 of the Bylaws states that notice 
of any special meeting must be given at least two (2) days previously thereto   
and may be delivered by electronic mail in addition to the methods of delivery  
previously available under the Bylaws.                                          

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.                                   

See the Exhibit Index set forth below for a list of exhibits included with this 
Current Report on Form 8-K.                                                     

8-K
3rd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 3rd
 EXHIBIT INDEX

EXHIBIT NUMBER     DESCRIPTION                                                  

3.2                Amendment to Bylaws                                          

8-K
Last Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 4th
SIGNATURES

  Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the        
undersigned thereunto duly authorized.                                          

                                  INKSURE TECHNOLOGIES, INC.
                    (Registrant)

                            By: /s/ Elie Housman
                            --------------------
                    Elie Housman
                                            Chairman and Chief Executive Officer

Date: April 4, 2008                                                             

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on / For Period End:		4/4/08		4
		3/31/08		1					10-Q,  NT 10-K
									List all Filings

10 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/23/23  Manuka, Inc.                      POS AM      5/22/23   53:4.5M                                   Z-K Global Ltd./FA
 5/12/23  Manuka, Inc.                      POS AM                52:4.5M                                   Z-K Global Ltd./FA
 5/03/23  Manuka, Inc.                      10-K/A     12/31/22   56:4.5M                                   Z-K Global Ltd./FA
 4/06/23  Manuka, Inc.                      10-K/A     12/31/22   56:4.5M                                   Z-K Global Ltd./FA
 3/31/23  Manuka, Inc.                      10-K       12/31/22   57:4.5M                                   Z-K Global Ltd./FA
 1/04/23  Manuka, Inc.                      S-1/A                 54:6M                                     Z-K Global Ltd./FA
12/20/22  Manuka, Inc.                      S-1/A                 56:6.1M                                   Z-K Global Ltd./FA
11/21/22  Manuka, Inc.                      S-1/A                 58:6.1M                                   Z-K Global Ltd./FA
 3/03/22  Manuka, Inc.                      10-K       12/31/21   44:2.6M                                   Z-K Global Ltd./FA
 3/30/21  Manuka, Inc.                      10-K       12/31/20   42:2M                                     Z-K Global Ltd./FA